- Filed
- Nov 5, 2020 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2020 · Oct 15, 2020 | 39.57M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2020 | 39.99M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2020 | 40.61M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 41.31M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 41.91M sh |
| Stock Repurchased | Q3 2020 · Sep 30, 2020 | $52.18M |
| Stock Repurchased | Q3 2020 · Sep 30, 2019 | $30.28M |
| Capex | Q3 2020 · Sep 30, 2020 | $35.69M |
| Capex | Q3 2020 · Sep 30, 2019 | $24.49M |
| Operating Cash Flow | Q3 2020 · Sep 30, 2020 | $142.92M |
| Operating Cash Flow | Q3 2020 · Sep 30, 2019 | $97.59M |
| Long Term Debt | Q3 2020 · Sep 30, 2020 | $7M |
| Long Term Debt | Q3 2020 · Dec 31, 2019 | $73M |
| Cash And Equivalents | Q3 2020 · Sep 30, 2020 | $116.35M |
| Cash And Equivalents | Q3 2020 · Dec 31, 2019 | $127.25M |
| Cash And Equivalents | Q3 2020 · Sep 30, 2019 | $142.57M |
| Cash And Equivalents | Q3 2020 · Dec 31, 2018 | $128.7M |
| Stockholders Equity | Q3 2020 · Sep 30, 2020 | $853.78M |
| Stockholders Equity | Q3 2020 · Jun 30, 2020 | $862.79M |
| Stockholders Equity | Q3 2020 · Mar 31, 2020 | $843.6M |
| Stockholders Equity | Q3 2020 · Dec 31, 2019 | $874.48M |
| Stockholders Equity | Q3 2020 · Sep 30, 2019 | $838.15M |
| Stockholders Equity | Q3 2020 · Jun 30, 2019 | $840.53M |
| Stockholders Equity | Q3 2020 · Mar 31, 2019 | $842.04M |
| Stockholders Equity | Q3 2020 · Dec 31, 2018 | $826.61M |
| Current Liabilities | Q3 2020 · Sep 30, 2020 | $280.03M |
| Current Liabilities | Q3 2020 · Dec 31, 2019 | $253.63M |
| Total Liabilities | Q3 2020 · Sep 30, 2020 | $472.35M |
| Total Liabilities | Q3 2020 · Dec 31, 2019 | $541.03M |
| Current Assets | Q3 2020 · Sep 30, 2020 | $551.51M |
| Current Assets | Q3 2020 · Dec 31, 2019 | $558.79M |
| Total Assets | Q3 2020 · Sep 30, 2020 | $1.33B |
| Total Assets | Q3 2020 · Dec 31, 2019 | $1.42B |
| Eps Diluted | Q3 2020 · Sep 30, 2020 | −$0.13 |
| Eps Diluted | Q3 2020 · Sep 30, 2020 | $0.76 |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | $0.44 |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | $0.98 |
| Eps Basic | Q3 2020 · Sep 30, 2020 | −$0.13 |
| Eps Basic | Q3 2020 · Sep 30, 2020 | $0.77 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | $0.44 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | $0.98 |
| Sga Expense | Q3 2020 · Sep 30, 2020 | $107.05M |
| Sga Expense | Q3 2020 · Sep 30, 2020 | $312.96M |
| Sga Expense | Q3 2020 · Sep 30, 2019 | $102.62M |
| Sga Expense | Q3 2020 · Sep 30, 2019 | $311.58M |
| Net Income | Q3 2020 · Sep 30, 2020 | −$5.09M |
| Net Income | Q3 2020 · Sep 30, 2020 | $31.06M |
| Net Income | Q3 2020 · Sep 30, 2019 | $18.11M |
| Net Income | Q3 2020 · Sep 30, 2019 | $41.06M |
| Operating Income | Q3 2020 · Sep 30, 2020 | −$2.1M |
| Operating Income | Q3 2020 · Sep 30, 2020 | $49.51M |
| Operating Income | Q3 2020 · Sep 30, 2019 | $24.71M |
| Operating Income | Q3 2020 · Sep 30, 2019 | $56.71M |
| Cost Of Revenue | Q3 2020 · Sep 30, 2020 | $275.21M |
| Cost Of Revenue | Q3 2020 · Sep 30, 2020 | $810.58M |
| Cost Of Revenue | Q3 2020 · Sep 30, 2019 | $253.67M |
| Cost Of Revenue | Q3 2020 · Sep 30, 2019 | $767.56M |